The role of fecal calprotectin in investigating inflammatory bowel diseases

The role of fecal calprotectin in investigating inflammatory bowel diseases

INTRODUCTION: Invasive and non-invasive tests can be used to evaluate the activity of inflammatory bowel diseases. OBJECTIVE: The aim of the present study was to investigate the role of fecal calprotectin in evaluating inflammatory bowel disease activity and the correlation of fecal calprotectin wit...

Full description

Bibliographic Details
Main Authors:	Mustafa Erbayrak, Cansel Turkay, Elife Eraslan, Hulya Cetinkaya, Benan Kasapoglu, Mehmet Bektas
Format:	Article
Language:	English
Published:	Elsevier España 2009-05-01
Series:	Clinics
Subjects:	Inflammatory bowel diseases Irritable bowel syndrome Fecal calprotectin
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322009000500009

Similar Items

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
by: Hui Won Jang, et al.
Published: (2016-10-01)

Fecal calprotectin concentration in the differential diagnosis of bowel diseases
by: M F Osipenko, et al.
Published: (2015-02-01)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
by: Hamid Kalantari, et al.
Published: (2015-01-01)

Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran
by: Majid Sharbatdaran, et al.
Published: (2018-01-01)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
by: von Arnim U, et al.
Published: (2016-04-01)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
by: You Jin Choi, et al.
Published: (2019-10-01)

Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series
by: Roberto Trasolini, et al.
Published: (2022-01-01)

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis
by: Jin-Tong Shi, et al.
Published: (2023-02-01)

Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study
by: Onişor Danusia, et al.
Published: (2018-07-01)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
by: Andrew S. Day, et al.
Published: (2017-06-01)

Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update
by: Cansel Turkay, et al.
Published: (2010-01-01)

Diagnostic Accuracy of Fecal Calprotectin in Discriminating Organic-Inflammatory Gastrointestinal Diseases and Functional Gastrointestinal Disorders in Older Patients
by: Antonella Gallo, et al.
Published: (2024-02-01)

Fecal Calprotectin Elevations Associated with Food Intolerance/Malabsorption Are Significantly Reduced with Targeted Diets
by: Wolfgang J. Schnedl, et al.
Published: (2023-02-01)

Age-Related Fecal Calprotectin Concentrations in Healthy Adults
by: Shin Young Park
Published: (2020-09-01)

Fecal Calprotectin in Inflammatory Bowel Disease
by: Jun Lee
Published: (2016-05-01)

Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
by: Cristina Romero-Mascarell, et al.
Published: (2022-09-01)

Can Giardia Infection Impair the Diagnostic Level of Fecal Calprotectin in Patients with Inflammatory Bowel Disease? A Case Report
by: Sara MOHAMMAD ALI GOL, et al.
Published: (2018-09-01)

Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population
by: Emily Garnett, et al.
Published: (2020-11-01)

The Usefulness of Tissue Calprotectin in Pediatric Crohn’s Disease—A Pilot Study
by: Edyta Szymanska, et al.
Published: (2023-01-01)

Fecal calprotectin in inflammatory bowel disease
by: Walsham NE, et al.
Published: (2016-01-01)

Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
by: Shaun S. C. Ho, et al.
Published: (2021-03-01)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
by: Cao Y, et al.
Published: (2021-12-01)

Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
by: Soheila Moein, et al.
Published: (2017-06-01)

IBS-Symptoms in IBD Patients—Manifestation of Concomitant or Different Entities
by: Patrycja Szałwińska, et al.
Published: (2020-12-01)

Evaluation of the diagnostic performance of estimated fecal calprotectin and serum intelectin-1 and C-reactive protein solo or in combination for differentiation between patients with query ulcerative colitis and irritable bowel syndrome
by: Rizk Sayad R. Sarhan, et al.
Published: (2023-11-01)

Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
by: Shiro Nakamura, et al.
Published: (2018-10-01)

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
by: Arno R. Bourgonje, et al.
Published: (2019-09-01)

Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases
by: Jagoda Pokryszka, et al.
Published: (2022-05-01)

Fecal Calprotectin, Chitinase 3-Like-1, S100A12 and Osteoprotegerin as Markers of Disease Activity in Children with Crohn’s Disease
by: Adriaan G. Volkers, et al.
Published: (2022-08-01)

Value of fecal calprotectin in the diagnosis of chronic inflammatory bowel diseases in children
by: T.V. Yaroshevska, et al.
Published: (2018-03-01)

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico [version 2; peer review: 2 approved]
by: Rebeca Pérez-Cabeza de Vaca, et al.
Published: (2021-02-01)

Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis
by: Julie Hejl, et al.
Published: (2018-03-01)

The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
by: Bianca J. Galgut, et al.
Published: (2018-01-01)

Assessing vitamin D as a biomarker in inflammatory bowel disease
by: Fiona Yeaman, et al.
Published: (2023-12-01)

Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience
by: Ferdinando D’Amico, et al.
Published: (2020-08-01)

Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
by: Fang Liu, et al.
Published: (2020-12-01)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
by: Yang Woon Lee, et al.
Published: (2019-01-01)

Diagnostic value of fecal calprotectin in primary care patients with gastrointestinal symptoms: A retrospective Swedish cohort study
by: Zlatica Rendek, et al.
Published: (2023-10-01)

Prevalence of spondyloarthritis in inflammatory bowel disease according ASAS and ultrassonography and its correlation with plasma calprotectin
by: Míriam Küster Huber, et al.
Published: (2024-04-01)

Impact of Fecal Calprotectin Measurement for Inflammatory Bowel Disease in Children with Alarm Symptoms
by: Burcu Güven, et al.
Published: (2022-06-01)